Product Information
REPAGLINIDE 2 MG TABLET is a generic product labeled by NorthStar Rx LLC, priced at $0.0917 per EA under NDC 72603081201. Its NADAC has been published 35 times since Oct 29, 2025.
Strength
2 mg/1
Manufacturer
NorthStar Rx LLCNDC
72603081201
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
REPAGLINIDEApproval Type
Generic (ANDA)
FDA Application
ANDA207209On Market Since
4/8/2025
Pharmacological Classes
Price Statistics
The NADAC for REPAGLINIDE 2 MG TABLET has been published 35 times since Oct 29, 2025, and over the history we have for it it has declined 2.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0917 per EA |
|---|---|
| All-time high | $0.0966 (Jan 14, 2026) |
| All-time low | $0.0859 (Mar 18, 2026) |
| 52-week high | $0.0966 |
| 52-week low | $0.0859 |
| Median price | $0.0910 |
| Average price | $0.0906 |
| Largest weekly change | +6.2% (Dec 17, 2025) |
| Weeks tracked | 35 |
| Tracking since | Oct 29, 2025 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of REPAGLINIDE 2 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for REPAGLINIDE 2 MG TABLET, manufactured by NorthStar Rx LLC, is $0.0917 per EA (NDC 72603081201), effective Jun 24, 2026.
How has the price of REPAGLINIDE 2 MG TABLET changed over time?
Over the history we have for it, the NADAC for REPAGLINIDE 2 MG TABLET has declined 2.4%. It has been tracked across 35 weekly CMS publications since Oct 29, 2025.
What are the highest and lowest recorded NADAC prices for REPAGLINIDE 2 MG TABLET?
Since Oct 29, 2025, the NADAC for REPAGLINIDE 2 MG TABLET has ranged from a low of $0.0859 (Mar 18, 2026) to a high of $0.0966 (Jan 14, 2026), with a median of $0.0910 per EA.
Are there cheaper alternatives to REPAGLINIDE 2 MG TABLET?
4 NADAC-published products share the same active ingredient, strength, and dosage form as REPAGLINIDE 2 MG TABLET, but none are currently priced below it.
Who manufactures REPAGLINIDE 2 MG TABLET?
REPAGLINIDE 2 MG TABLET (NDC 72603081201) is labeled by NorthStar Rx LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification